MediGo · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of MediGo is 0.1% (very low). The 2025 annual accounts show equity of €218k and a net result of €21k. Equity is growing by ~7.2% per year across the filed fiscal years. Its solvency ranks better than 49% of 2219 sector peers (fiscal year 2025). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 8 annual accounts.

Signals

1 signal · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2024 and 2025).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

How we compute the deadline

The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	05-06-2026	56 d early	2026-00139809
31-12-2024	31-07-2025	11-06-2025	50 d early	2025-00133105
31-12-2023	31-07-2024	06-06-2024	55 d early	2024-00112698
31-12-2022	31-07-2023	06-06-2023	55 d early	2023-00108971
31-12-2021	31-07-2022	02-06-2022	59 d early	2022-20043332
31-12-2020	31-07-2021	16-06-2021	45 d early	2021-20500017
31-12-2019	31-07-2020	23-06-2020	38 d early	2020-20800572
31-12-2018	31-07-2019	24-06-2019	37 d early	2019-22500091
31-12-2017	31-07-2018	13-07-2018	18 d early	2018-33500052
31-12-2016	31-07-2017	06-06-2017	55 d early	2017-15700562

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Established

Founded in 2011, 15 years in business.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.1% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Annual accounts: healthy financial profile −Long track record −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€21k-48.9%

Working capital€148k-45.2%

CSV export

Annual accounts & ratios

Source: NBB · 2025

Annual accounts filed on 05-06-2026 with the NBB · fiscal year 2025 · micro

Operating resultNet result

Trajectory (indicative)

Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.

growing Equity: growth of ~7.2%/year over 8 fiscal years, indicative, assuming unchanged policy.

Solid line = filed figures · dashed = extended trend · area = indicative range.

How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison

Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	57.1%	58.2%	better than 49% of 2219 sector peers
Net result	€21k	€60k	better than 22% of 2217 sector peers
Equity	€218k	€74k	better than 80% of 2219 sector peers
Gross operating margin	€87k	€95k	better than 46% of 2219 sector peers
Total assets	€382k	€187k	better than 78% of 2219 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

Sector position over time

Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).

Solvency P49

Weakening position over 2020-2025 · n=652-6584

Net result P22

Weakening position over 2020-2025 · n=653-6578

Equity P80

Stable position over 2020-2025 · n=652-6584

Gross operating margin P46

Stable position over 2020-2025 · n=653-6586

Describes the position versus peers, not a forecast.

EBITDA

€86k

+9.4% 18-25

Net profit

€21k

-48.9% 18-25

Cash flow

€44k

-31.3% 18-25

Total assets

€382k

-9.1% 18-25

Equity

€218k

-39.5% 18-25

Working capital

€148k

-45.2% 18-25

Income taxes

€9k

-45.4% 18-25

Dividends

€163k

+186.0% 18-25

Show 9 other metrics

Debt

€164k

+174.1% 18-25

Debt ≤ 1y

€164k

+174.1% 18-25

Current ratio

1.90

-65.5% 18-25

Quick ratio

1.90

-65.5% 18-25

Solvency

57.1%

-33.5% 18-25

Debt / equity

0.75

+353.0% 18-25

ROE

9.5%

-15.5% 18-25

ROA

5.4%

-43.8% 18-25

Interest coverage

2.46

-99.5% 18-25

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€86k
Net profit	€21k
Cash flow	€44k
Staff costs	-
Income taxes	€9k
Dividends	€163k
Total assets	€382k
Equity	€218k
Debt	€164k
of which ≤ 1y	€164k
of which > 1y	-
Working capital	€148k
Employees (FTE)	-

Ratios (computed)

	2025
Current ratio	1.90
Quick ratio	1.90
Working capital ratio	38.8%
Solvency	57.1%
Debt / equity	0.75
Long-term debt ratio	-
Interest coverage	2.46
Gross margin	-
Net margin	-
ROA	5.4%
ROE	9.5%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2025

Assets

Fixed assets €70k · 18.3% Current assets €312k · 81.7%

Equity & liabilities

Equity €218k · 57.1% Debt €164k · 42.9%

Full annual accounts (21 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€382k
Fixed assets	21/28	€70k
Tangible fixed assets	22/27	€70k
Current assets	29/58	€312k
Amounts receivable within one year	40/41	€14k
Cash & bank	54/58	€296k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€382k
Equity	10/15	€218k
Contributions / capital	10/11	€19k
Reserves	13	€137k
Accumulated profits (losses)	14	€62k
Amounts payable	17/49	€164k
Amounts payable within one year	42/48	€164k
Income statement
Gross operating margin	9900	€87k
Operating result	9901	€63k
Financial income	75	€2k
Financial charges	65	€35k
Result before taxes	9903	€30k
Income taxes	67/77	€9k
Net result for the period	9904	€21k
Result to be appropriated	9905	€21k

This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2025 · computed

78 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

2 companies at this address See who is registered here

Establishment units

1 location

MediGo

Rue Saucis 15, 1325 Chaumont-GistouxActiviteiten van huisartspraktijken

since 20112.198.451.451

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area1,113 m²

Buildings1

Building footprint164 m²

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
25018F0076/00C000	Wallonia	1,113 m²	1 · 164 m²	-

Methodology

via registered seat: 1

1 of 1 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

0 of 5 acts read

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

The insolvency signals above come from a separate source; the KBO register is the second source and appears as the legal situation on this page.

Analysis

Financial profile

5 of 5 axes measured

75 / 100

Exceptional profile, strong across almost every axis.

All 5 axes are computed from data Checked has read.

Health 78

Profitability 48

Solvency 96

Growth 52

Stability 100

Credit advice

verdict per customer and amount

Similar

Similar companies

Comparable size, same sector

Dr Florence Desmidt

BE 1003.551.607 · Oosterzele

Eq €218k→

DR. ALEXANDRA de JONG, HUISARTS

BE 0762.573.319 · Maldegem

Eq €218k→

DOKTER ORIANA BONNE

BE 0792.472.974 · Brecht

Eq €218k→

DOC

BE 0795.886.384 · Aalst

Eq €218k→

Dr. Nele Balcaen, huisarts

BE 0794.725.255 · Kortenberg

Eq €218k→

We hold annual accounts for 2,099 of the 9,096 companies in this sector. 1,761 of them are within a factor 10 of this company's equity.

See full sector →

Company registry

Company registry (CBE)

Crossroads Bank

Activities

Huisartspraktijken86210Activiteiten van huisartspraktijken86210Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995

Primary activity highlighted.

Names & trade names

Legal nameFR	MediGo
Legal nameNL	MediGo

Registered office

Rue Saucis 15

1325 Chaumont-Gistoux, Belgium

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.